A Study to Evaluate the Safety, Tolerability and PK of SK-09
A Study to Evaluate the Safety, Tolerability and PK of SK-09
Recruiting · NCT07267026 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability and PK of SK-09 | focal segmental glomerulosclerosis, macular corneal dystrophy | Recruiting | Phase 1 | 2026-09-03 | NCT07267026 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Consun Pharmaceutical Group | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Q-Pharm Pty Ltd. | Herston | Australia | 1 |